Serum Levels of Soluble Forms of Fas and FasL in Patients with Pancreatic and Papilla of Vater Adenocarcinomas

Stavros Anagnostoulis, Helen Bolanaki, Byron Asimakopoulos, Dimitrios Ouroumidis, Maria Koutini, Spyridon Patris, Ioannis Tzimagiorgis, Anastasios J. Karayiannakis · 2025

Read Serum Levels of Soluble Forms of Fas and FasL in Patients with Pancreatic and Papilla of Vater Adenocarcinomas by Stavros Anagnostoulis, Helen Bolanaki, Byron Asimakopoulos, Dimitrios Ouroumidis, Maria Koutini, Spyridon Patris, Ioannis Tzimagiorgis, Anastasios J. Karayiannakis (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12784731.txt.

Description

Stavros Anagnostoulis and co-authors measure blood markers in pancreatic cancer patients in 2025. Two soluble forms of a cell-death signal pair may reflect how tumors evade that death path. The team asks whether their levels predict spread and survival.

Blood from eighty-two pancreatic and fourteen related cancer patients was compared with healthy controls. Patients showed higher levels of one form and lower of the other. Both patterns tracked node spread, distant spread, and advanced stage. After surgery that removed the tumor fully, levels moved back toward normal, while they stayed fixed when the tumor could not be removed.

Catalog record

CREATORStavros Anagnostoulis, Helen Bolanaki, Byron Asimakopoulos, Dimitrios Ouroumidis, Maria Koutini, Spyridon Patris, Ioannis Tzimagiorgis, Anastasios J. Karayiannakis
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12784731

Browse the full library · About the Tower of Babel